Atlas Trials

Letermovir Use in Heart Transplant Recipients

Clinical trial NCT04904614 · COMPLETED

Trial details

NCT number
NCT04904614
Sponsor
Tufts Medical Center
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Cytomegalovirus DiseaseCytomegalovirus InfectionsHeart Transplant InfectionAntiviral ToxicityNeutropenia
Start date
2022-01-05
Primary completion
2025-01-14
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.